Katzen Eye Group partners with RxTrials

Monday, November 14, 2011 12:06 PM

Katzen Eye Group, a private provider of eye care services in Maryland, has partnered with RxTrials, to provide clinical research study support in ophthalmology and optometry.

With 18 clinical providers, Katzen Eye Group serves an active and varied patient population of 180,000, for indications that include cataract surgery, retina, glaucoma, refractive surgery, and dry eye, as well as routine eye and contact lens care.

"We have the ideal population to help advance eye care," explains Richard C. Edlow, DO, Katzen Eye Group's CEO. "Our electronic medical records system is optimized to enable us to identify and contact appropriate potential study subjects. We are very pleased to partner with RxTrials, who in our opinion, has the expertise and experience we need to do research right."

Katzen Eye Group is equipped to conduct clinical research studies, with
comprehensive testing and diagnostic capabilities and essential equipment in all three locations. Past research experience includes studies in macular edema, age-related macular degeneration, retinal detachment, and implants, among others. All 11 principal investigators are trained in clinical study practice, human subject protections, and federal compliance standards.

"As we look to grow our network of partner sites strategically, we seek sites that can adhere to our high standards for quality, professionalism and ethics," said Adam Chasse, RxTrials' vice president of corporate development. "Katzen Eye Group is a high quality addition to our network and enables us to enhance our therapeutic capabilities in ophthalmology and optometry."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs